Dr. Baxter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6621 Fannin St
Cc1410.00
Houston, TX 77030Phone+1 832-822-4200- Is this information wrong?
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2006 - 2009
- Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonResidency, Pediatrics, 2002 - 2006
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2002
Certifications & Licensure
- TX State Medical License 2008 - 2024
- DE State Medical License 2005 - 2013
- PA State Medical License 2002 - 2012
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Hospice and Palliative Medicine
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas Start of enrollment: 2012 Feb 01
- Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Start of enrollment: 2015 Jul 14
- Panobinostat in Treating Younger Patients With Progressive Diffuse Intrinsic Pontine Glioma Start of enrollment: 2016 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsPhase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).Monje, M., Cooney, T., Glod, J., Huang, J., Peer, C., Faury, D., Baxter, P., Kramer, K., Lenzen, A., Robison, N., Kilburn, L., Vinitsky, A., Figg, W., Jabado, N., Foul...> ;Neuro-Oncology. 2023 Dec 8
- 6 citationsPhase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor.Santhosh A Upadhyaya, Olivia Campagne, Catherine A Billups, Brent A Orr, Arzu Onar-Thomas, Ruth G Tatevossian, Roya Mostafavi, Jason R Myers, Anna Vinitsky, Daniel C M...> ;Neuro-Oncology. 2023 Feb 14
- Phase II study of everolimus for recurrent or progressive pediatric ependymoma.Daniel C Bowers, Veena Rajaram, Matthias A Karajannis, Sharon L Gardner, Jack Meng-Fen Su, Patricia Baxter, Sonia Partap, Laura J Klesse> ;Neuro-Oncology Advances. 2023 Feb 10
- Join now to see all
Press Mentions
- New Phase 1 Clinical Trial for Pediatric CNS TumorsFebruary 24th, 2022
Hospital Affiliations
- Texas Children's HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: